HNDS0129-01#A

General

Cell Line

hPSCreg name BCHi021-A
Cite as:
BCHi021-A
Alternative name(s)
HNDS0129-01#A
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
BCHi021-A-1
(HNDS0129-01#A CNC7(+/-))
Donor diseases:
Phelan-McDermid syndrome
BCHi021-A-2
(HNDS0129-01#A CC20(+/+))
Donor diseases:
Phelan-McDermid syndrome
BCHi021-A-3
(HNDS0129-01#A CC47(-/-))
Donor diseases:
Phelan-McDermid syndrome
UOHi003-A
(UOHi001 with its alternative name as UOHi001SHANK3)
Donor diseases:
Phelan-McDermid Syndrome
IMGTi001-B
(iTAF5-32)
Donor diseases:
Phelan-McDermid syndrome
IMGTi001-A
(iTAF5-29)
Donor diseases:
Phelan-McDermid syndrome
Last update 29th February 2024
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Children's Hospital (BCH)

External Databases

BioSamples SAMEA115361525

General Information

* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
Subclones

Donor Information

General Donor Information

Sex male
Ethnicity Asian

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
The donor is affected.
Synonyms
  • 22q13 deletion
  • Phelan McDermid syndrome
  • Phelan-McDermid syndrome
  • monosomy 22q13
  • monosomy type 22q13
  • 22q13.3 deletion syndrome
  • PHELAN-McDermid syndrome
  • PHMDS
  • chromosome 22Q13.3 deletion syndrome
  • deletion 22q13.3 syndrome
  • telomeric 22Q13 monosomy syndrome
show more synonyms

Karyotyping (Donor)

Has the donor karyotype been analysed?
No

External Databases (Donor)

BioSamples SAMEA115361526

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? Yes
Do you (Depositor/Provider) hold the original Donor Consent Form? Yes
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. pseudonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? Yes
How may genetic information associated with the cell line be accessed? Open Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved?
Approval number
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

Source cell line name PBMC
Source cell type
A peripheral blood cell with a single nucleus. This category includes lymphocytes and monocytes.
Synonyms
  • PERIPHERAL BLOOD MONONUCLEAR CELL
  • Peripheral Blood Mononuclear Cell
  • PBMC

Reprogramming method

Vector type Non-integrating
Vector Sendai virus

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Surface coating Matrigel/Geltrex
Feeder cells
No
Medium Other medium:
Base medium: Stemflex
Main protein source: Bovine Serum Albumin (BSA)
Serum concentration: 1 %
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
Yes
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
Yes

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
NANOG
Yes
SSEA-4
Yes
TRA 1-60
Yes
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
Marker Expressed
AFP
Yes
KLF5
Yes
SST
Yes
Morphology
Mesoderm
Ont Id: UBERON_0000926
Marker Expressed
HAND2
Yes
RGS4
Yes
SNAIL2
Yes
Morphology
Ectoderm
Ont Id: UBERON_0000924
Marker Expressed
EN1
Yes
MAP2
Yes
NR2F2
Yes
Morphology

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46, XY; no clonal abnormalities
Karyotyping method: G-Banding

Other Genotyping (Cell Line)